Clinical Research

With the unique setting of the clinical services of DDI, clinical research and trials are conducted in an easy and smooth manner, where all the needed recruitment and procedures are conducted within the Medical Sector. In 2024, we published a total of 22 publications, 11 of which are original Medical Sector research with a median impact factor of 3.2, 3 reviews, 3 original research in collaboration with the Research Sector, and 5 other publications (case reports, expert consensus, trial protocols). We had a total of 17 ongoing studies, 6 of which are clinical trials.

Some of our ongoing studies include:

• The vascular brain changes in people with diabetes.

(in collaboration with Sunnybrook Research Institute, Toronto)

Assess people with diabetes by utilizing brain MRI scans and implementing the first Arabic cognitive battery.

• Obesity treatments to improve diabetes (in collaboration with Ulster University/SOPHIA and EU Commission)

Our pioneering work in T1DM and obesity has led us to be included in the SOPHIA Consortium and EU Commission. In addition, the results of this novel work has bridged the way to getting grant approval for a Breakthrough T1DM (formerly JDRF) study, the first of its kind in Kuwait.

We are always striving towards enhancing the recognition of DDI regionally and internationally, and in 2024 the medical sector presented a total of 41 oral and poster presentations at major regional and international conferences.